Beam Therapeutics
BEAM
#4317
Rank
ยฃ1.88 B
Marketcap
ยฃ18.54
Share price
3.49%
Change (1 day)
22.68%
Change (1 year)

Revenue for Beam Therapeutics (BEAM)

Revenue in 2025 (TTM): ยฃ0.10 Billion

According to Beam Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.10 Billion. an increase over the revenue in the year 2024 that were of ยฃ50.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Beam Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ0.10 B105.01%
2024 ยฃ50.61 M-82.93%
2023 ยฃ0.29 B488.76%
2022 ยฃ50.35 M31.11%
2021 ยฃ38.4 M218033.72%
2020 ยฃ0.01 M28.27%
2019 ยฃ0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA